Technical aspects of minimal residual disease detection in carcinoma patients.
about
Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts.Early postoperative magnet resonance tomography after resection of cerebral metastases.Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
P2860
Technical aspects of minimal residual disease detection in carcinoma patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Technical aspects of minimal residual disease detection in carcinoma patients.
@ast
Technical aspects of minimal residual disease detection in carcinoma patients.
@en
Technical aspects of minimal residual disease detection in carcinoma patients.
@nl
type
label
Technical aspects of minimal residual disease detection in carcinoma patients.
@ast
Technical aspects of minimal residual disease detection in carcinoma patients.
@en
Technical aspects of minimal residual disease detection in carcinoma patients.
@nl
prefLabel
Technical aspects of minimal residual disease detection in carcinoma patients.
@ast
Technical aspects of minimal residual disease detection in carcinoma patients.
@en
Technical aspects of minimal residual disease detection in carcinoma patients.
@nl
P2860
P356
P1476
Technical aspects of minimal residual disease detection in carcinoma patients.
@en
P2093
Doeberitz MK
P2860
P304
P356
10.1002/SSU.1042
P577
2001-06-01T00:00:00Z